File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/s41419-020-2553-6
- Scopus: eid_2-s2.0-85085854827
- PMID: 32483123
- WOS: WOS:000539286100002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation
Title | CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation |
---|---|
Authors | |
Keywords | A-549 cell line cancer stem cell cancer survival cell renewal controlled study |
Issue Date | 2020 |
Publisher | Nature Publishing Group: Open Access Journals - Option C. The Journal's web site is located at http://www.nature.com/cddis/index.html |
Citation | Cell Death & Disease, 2020, v. 11, p. article no. 410 How to Cite? |
Abstract | Tumor initiating cells (TIC) of lung cancer are mainly induced by stress-related plasticity. Calcium/Calmodulin dependent protein kinase II alpha (CAMK2A) is a key calcium signaling molecule activated by exogenous and endogenous stimuli with effects on multiple cell functions but little is known about its role on TIC. In human lung adenocarcinomas (AD), CAMK2A was aberrantly activated in a proportion of cases and was an independent risk factor predicting shorter survivals. Functionally, CAMK2A enhanced TIC phenotypes in vitro and in vivo. CAMK2A regulated SOX2 expression by reducing H3K27me3 and EZH2 occupancy at SOX2 regulatory regions, leading to its epigenetic de-repression with functional consequences. Further, CAMK2A caused kinase-dependent phosphorylation of EZH2 at T487 with suppression of EZH2 activity. Together, the data demonstrated the CAMK2A-EZH2-SOX2 axis on TIC regulation. This study provided phenotypic and mechanistic evidence for the TIC supportive role of CAMK2A, implicating a novel predictive and therapeutic target for lung cancer. |
Persistent Identifier | http://hdl.handle.net/10722/293872 |
ISSN | 2023 Impact Factor: 8.1 2023 SCImago Journal Rankings: 2.447 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, SQ | - |
dc.contributor.author | Liu, J | - |
dc.contributor.author | Qin, J | - |
dc.contributor.author | ZHU, Y | - |
dc.contributor.author | Tin, VPC | - |
dc.contributor.author | Yam, JWP | - |
dc.contributor.author | Wong, MP | - |
dc.contributor.author | Xiao, Z | - |
dc.date.accessioned | 2020-11-23T08:23:01Z | - |
dc.date.available | 2020-11-23T08:23:01Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Cell Death & Disease, 2020, v. 11, p. article no. 410 | - |
dc.identifier.issn | 2041-4889 | - |
dc.identifier.uri | http://hdl.handle.net/10722/293872 | - |
dc.description.abstract | Tumor initiating cells (TIC) of lung cancer are mainly induced by stress-related plasticity. Calcium/Calmodulin dependent protein kinase II alpha (CAMK2A) is a key calcium signaling molecule activated by exogenous and endogenous stimuli with effects on multiple cell functions but little is known about its role on TIC. In human lung adenocarcinomas (AD), CAMK2A was aberrantly activated in a proportion of cases and was an independent risk factor predicting shorter survivals. Functionally, CAMK2A enhanced TIC phenotypes in vitro and in vivo. CAMK2A regulated SOX2 expression by reducing H3K27me3 and EZH2 occupancy at SOX2 regulatory regions, leading to its epigenetic de-repression with functional consequences. Further, CAMK2A caused kinase-dependent phosphorylation of EZH2 at T487 with suppression of EZH2 activity. Together, the data demonstrated the CAMK2A-EZH2-SOX2 axis on TIC regulation. This study provided phenotypic and mechanistic evidence for the TIC supportive role of CAMK2A, implicating a novel predictive and therapeutic target for lung cancer. | - |
dc.language | eng | - |
dc.publisher | Nature Publishing Group: Open Access Journals - Option C. The Journal's web site is located at http://www.nature.com/cddis/index.html | - |
dc.relation.ispartof | Cell Death & Disease | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | A-549 cell line | - |
dc.subject | cancer stem cell | - |
dc.subject | cancer survival | - |
dc.subject | cell renewal | - |
dc.subject | controlled study | - |
dc.title | CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation | - |
dc.type | Article | - |
dc.identifier.email | Wang, SQ: wangsq47@hku.hk | - |
dc.identifier.email | Liu, J: jingliue@hku.hk | - |
dc.identifier.email | Tin, VPC: pctin@hku.hk | - |
dc.identifier.email | Yam, JWP: judyyam@pathology.hku.hk | - |
dc.identifier.email | Wong, MP: mwpik@hku.hk | - |
dc.identifier.email | Xiao, Z: xiaozj@hku.hk | - |
dc.identifier.authority | Yam, JWP=rp00468 | - |
dc.identifier.authority | Wong, MP=rp00348 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1038/s41419-020-2553-6 | - |
dc.identifier.pmid | 32483123 | - |
dc.identifier.pmcid | PMC7264342 | - |
dc.identifier.scopus | eid_2-s2.0-85085854827 | - |
dc.identifier.hkuros | 319888 | - |
dc.identifier.hkuros | 318201 | - |
dc.identifier.volume | 11 | - |
dc.identifier.spage | article no. 410 | - |
dc.identifier.epage | article no. 410 | - |
dc.identifier.isi | WOS:000539286100002 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 2041-4889 | - |